Notices. DEPARTMENT OF JUSTICE
921 words·~4 min read·
/register/2013/06/18/2013-14446A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application; Lipomed Pursuant to Title 21 Code of Federal Regulations 1301.34 (a), this is notice that on March 22, 2013, Lipomed, One Broadway, Cambridge, Massachusetts 02142, made application by renewal to the Drug Enforcement Administration
(DEA)for registration as an importer of the following basic classes of controlled substances: Drug Schedule Cathinone
(1235)I Methcathinone
(1237)I 4-Mephedrone
(1248)I N-Ethylamphetamine
(1475)I N,N-Dimethylamphetamine
(1480)I Fenethylline
(1503)I Aminorex
(1585)I 4-Methylaminorex (cis isomer)
(1590)I Gamma Hydroxybutyric Acid
(2010)I Methaqualone
(2565)I Mecloqualone
(2572)I JWH-250
(6250)I SR-18 (Also known as RCS-8)
(7008)I JWH-019
(7019)I JWH-081
(7081)I SR-19 (Also known as RCS-4)(7104) I JWH-018 AND AM-678
(7118)I JWH-122
(7122)I JWH-073
(7173)I JWH-200
(7200)I AM-2201
(7201)I JWH-203
(7203)I Alpha-ethyltryptamine
(7249)I Ibogaine
(7260)I CP-47497
(7297)I CP-47497 C8 Homologue
(7298)I Lysergic acid diethylamide
(7315)I 2C-T-7
(7348)I Marihuana
(7360)I Tetrahydrocannabinols
(7370)I Parahexyl
(7374)I Mescaline
(7381)I 2C-T-2
(7385)I 3,4,5-Trimethoxyamphetamine
(7390)I 4-Bromo-2,5-dimethoxyamphetamine
(7391)I 4-Bromo-2,5-dimethoxyphenethylamine
(7392)I 4-Methyl-2,5-dimethoxyamphetamine
(7395)I 2,5-Dimethoxyamphetamine
(7396)I JWH-398
(7398)I 2,5-Dimethoxy-4-ethylamphetamine
(7399)I 3,4-Methylenedioxyamphetamine
(7400)I 5-Methoxy-3,4-methylenedioxyamphetamine
(7401)I N-Hydroxy-3,4-methylenedioxyamphetaimine
(7402)I 3,4-Methylenedioxy-N-ethylamphetamine
(7404)I 3,4-Methylenedioxymethamphetamine
(7405)I 4-Methoxyamphetamine
(7411)I 5-Methoxy-N-N-dimethyltryptamine
(7431)I Alpha-methyltryptamine
(7432)I Bufotenine
(7433)I Psilocybin
(7437)I Psilocyn
(7438)I 5-Methoxy-N,N-diisopropyltryptamine
(7439)I N-Ethyl-1-phenylcyclohexylamine
(7455)I 1-[1-(2-Thienyl)cyclohexyl]piperidine
(7470)I 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine
(7473)I N-Ethyl-3-piperidyl benzilate
(7482)I N-Methyl-3-piperidyl benzilate
(7484)I N-Benzylpiperazine
(7493)I 2C-D
(7508)I 2C-E
(7509)I 2C-H
(7517)I 2C-I
(7518)I 2C-C
(7519)I 2C-N
(7521)I 2C-P
(7524)I 2C-T-4
(7532)I MDPV
(7535)I Methylone
(7540)I AM-694
(7694)I Acetyldihydrocodeine
(9051)I Benzylmorphine
(9052)I Codeine-N-oxide
(9053)I Cyprenorphine
(9054)I Desomorphine
(9055)I Etorphine (except HCI)
(9056)I Codeine methylbromide
(9070)I Dihydromorphine
(9145)I Difenoxin
(9168)I Heroin
(9200)I Hydromorphinol
(9301)I Methyldesorphine
(9302)I Methyldihydromorphine
(9304)I Morphine methylbromide
(9305)I Morphine methylsulfonate
(9306)I Morphine-N-oxide
(9307)I Myrophine
(9308)I Nicocodeine
(9309)I Nicomorphine
(9312)I Normorphine
(9313)I Pholcodine
(9314)I Thebacon
(9315)I Acetorphine
(9319)I Acetylmethadol
(9601)I Allylprodine
(9602)I Alphacetylmethadol except levo-alphacetyl-methadol
(9603)I Alphamethadol
(9605)I Dioxaphetyl butyrate
(9621)I Dipipanone
(9622)I Elhylmethylthiambutene
(9623)I Etonitazene
(9624)I Etoxeridine
(9625)I Furethidine
(9626)I Hydroxypethidine
(9627)I Ketobemidone
(9628)I Levomoramide
(9629)I Levophenacylmorphan
(9631)I Morpheridine
(9632)I Noracymethadol
(9633)I Norlevorphanol
(9634)I Normethadone
(9635)I Norpipanone
(9636)I Phenadoxone
(9637)I Phenampromide
(9638)I Phenoperidine
(9641)I Piritramide
(9642)I Proheptazine
(9643)I Properidine
(9644)I Racemoramide
(9645)I Trimeperidine
(9646)I Phenomorphan
(9647)I Propiram
(9649)I Tilidine
(9750)I Para-Flouorofentanyl
(9812)I 3-Methylfentanyl
(9813)I Acetyl-alpha-methylfentanyl
(9815)I Beta-hydroxy-3-methylfentanyl
(9831)I Amphetamine
(1100)II Methamphetamine
(1105)II Lisdexamfetamine
(1205)II Phenmetrazine
(1631)II Methylphenidate
(1724)II Amobarbital
(2125)II Pentobarbital
(2270)II Secobarbital
(2315)II Glutethimide
(2550)II Nabilone
(7379)II 1-Phenylcyclohexylamine
(7460)II Phencyclidine
(7471)II 4-Anilino-N-phenethyl-4-piperidine
(8333)II Phenylacetone
(8501)II 1-Piperidinocyclohexanecarbonitrile
(8603)II Alphaprodine
(9010)II Anileridine
(9020)II Cocaine
(9041)II Codeine
(9050)II Etorphine HCI
(9059)II Dihydrocodeine
(9120)II Oxycodone
(9143)II Hydromorphone
(9150)II Diphenoxylate
(9170)II Ecgonine
(9180)II Ethylmorphine
(9190)II Hydrocodone
(9193)II Levomethorphan
(9210)II Levorphanol
(9220)II Isomethadone
(9226)II Meperidine
(9230)II Meperidine intermediate-B
(9233)II Metazocine
(9240)II Methadone
(9250)II Methadone intermediate
(9254)II Metopon
(9260)II Dextropropoxyphene, bulk (non-dosage forms)
(9273)II Morphine
(9300)II Thebaine
(9333)II Dihydroetorphine
(9334)II Levo-alphacetylmethadol
(9648)II Oxymorphone
(9652)II Noroxymorphone
(9668)II Phenazocine
(9715)II Piminodine
(9730)II Racemethorphan
(9732)II Racemorphan
(9733)II Alfentanil
(9737)II Remifentanil
(9739)II Sufentanil
(9740)II Carfentanil
(9743)II Tapentadol
(9780)II Bezitramide
(9800)II Fentanyl
(9801)II The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes. Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances listed in schedules I and II, which fall under the authority of section 1002(a)(2)(B) of the Act 21 U.S.C. 952 (a)(2)(B) may, in the circumstances set forth in 21 U.S.C. 958(i), file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43, and in such form as prescribed by 21 CFR 1316.47. Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than July 18, 2013. This procedure is to be conducted simultaneously with, and independent of, the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice published in the **Federal Register** on September 23, 1975, 40 FR 43745-46, all applicants for registration to import a basic class of any controlled substance in schedules I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and
(f)are satisfied. Dated: June 7, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013-14446 Filed 6-17-13; 8:45 am]
Connectionstraces to 6
Traces to 6 documents
Citation graph
cites case law
Notices
DEPARTMENT OF JUSTICE
Cites 6Cited by 0 across 0 sources